Intracortical inhibition and facilitation in migraine - A transcranial magnetic stimulation study

Headache

Volumn 47, Issue 3, 2007, Pages 364-370

  Siniatchkin, Michael ^a   Kröner Herwig, Birgit ^b   Kocabiyik, Ebru ^b   Rothenberger, Aribert ^b  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Excitability; Facilitation; Migraine; Transcranial magnetic stimulation

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; DISEASE ACTIVITY; EVOKED MUSCLE RESPONSE; FACILITATION; FEMALE; HUMAN; MIGRAINE; MOTOR CORTEX; NEUROMODULATION; PRIORITY JOURNAL; TRANSCRANIAL MAGNETIC STIMULATION;

ADULT; CEREBRAL CORTEX; FEMALE; HUMANS; MIGRAINE WITHOUT AURA; NEURAL INHIBITION; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 33947277805     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2007.00727.x     Document Type: Article

References (45)

1. Schoenen J, Ambrosini A, Sandor PS, Maertens de Noordhout A. Evoked potentials and transcranial megnetic stimulation in migraine: Published data and viewpoint on their pathophysiologic significance. Clin Neurophysiol. 2003;114:955-972.
2. Welch KM. Contemporary concepts of migraine pathogenesis. Neurology. 2003;28(suppl 4):2-8.
3. Schoenen J. Neurophysiological features of the migraineous brain. Neurol Sci. 2006;27(suppl 2):77-81.
4. George MS, Nahas Z, Kozol FA, et al. Mechanisms and the current state of transcranial magnetic stimulation. CNS Spectr. 2003;8:496-514.
5. Kobayashi M, Paskual-Leone A. Transcranial magnetic stimulation in neurology. Lancet Neurol. 2003;2:145-156.
6. Mulleners WM, Chronicle EP, Palmer JE, Koehler PJ, Vredeveld JW. Suppression of perception in migraine: Evidence for reduced inhibition in the visual cortex. Neurology. 2001;56:178-183.
7. Aurora SK, Barrodale P, Chronicle EP, Mulleners WM. Cortical inhibition is reduced in chronic and episodic migraine and demonstrates a spectrum of illness. Headache. 2005;45:546-552.
8. Chronicle EP, Pearson A, Mulleners WM. Objective assessment of cortical excitability in migraine with and without aura. Cephalalgia. 2006;26:801-808.
9. Aurora SK, al-Sayeed F, Welch KM. The cortical silent period is shortened in migraine with aura. Cephalalgia. 1999;19:708-712.
10. Afra J, Marcia A, Gerard P, Maertens de Noordhout A, Schoenen J. Interictal cortical excitability in migraine: A study using transcranial magnetic stimulation of motor and visual cortices. Ann Neurol. 1998;44:209-215.
11. Werhahn KJ, Wiseman K, Herzog J, Forderreuther S, Dichgans M, Straube A. Motor cortex excitability in patients with migraine with aura and hemiplegic migraine. Cephalalgia. 2000;20:45-50.
12. Chen R. Interactions between inhibitory and excitatory circuits in the human motor cortex. Exp Brain Res. 2004;154:1-10.
13. Sanger TD, Garg RR, Chen R. Interactions between 2 different inhibitory systems in the human motor cortex. J Physiol. 2001;530:307-317.
14. Ziemann U. Intracortical inhibition and facilitation in the conventional paired TMS paradigm. In: Paulus W, Hallett M, Rossini PM, Rothwell JC, eds. Transcranial Magnetic Stimulation (EEG suppl 51). Amsterdam: Elsevier Science B.V.; 1999:127-136.
15. Ziemann U, Chen R, Cohen LG, Hallett M. Dextromethorphan decreases the excitability of the human motor cortex. Neurology. 1998;51:1320-1324.
16. Liepert J, Schwenkreis P, Tegenthoff M, Malin JP. The glutamate antagonist riluzole suppresses intracortical facilitation. J Neural Transm. 1997;104:1207-1214.
17. Ziemann U, Tergau F, Bruns D, Baudewig J, Paulus W. Changes in human motor cortex excitability induced by dopaminergic and anti-dopaminergic drugs. Electroencephalogr Clin Neurophysiol. 1997;105:430-437.
18. Ramadan NM. The link between glutamate and migraine. CNS Spectr. 2003;8:446-449.
19. Marcia A, Afra J, Schoenen J. Dopamine and migraine: A review of pharmacological, biochemical, neurophysiological, and therapeutic data. Cephalalgia. 1998;18:174-182.
20. International Headache Society, Headache classification committee. Classification and diagnostic criteria for headache disorders, cranial neuralgia, and facial pain. Cephalalgia. 1988;8(suppl 7):1-96.
21. Gobel H. Paper-pencil tests for retrospective and prospective evaluation of primary headaches on the basis of the IHS criteria. Headache. 1994;34:564-568.
22. Rossini PM, Barker AT, Berardelli A, et al. Noninvasive electrical and magnetic stimulation of the brain, spinal cord and roots: Basic princeples and procedures for routine clinical application. Report of an IFCN committee. Electroenceph Clin Neurophysiol 1994;91:79-82.
23. Ziemann U, Paulus W, Rothenberger A. Decreased motor inhibition in Tourette's disorder: Evidence from transcranial magnetic stimulation. Am J Psychiatry. 1997;154:1277-1284.
24. Manganotti P, Bongiovanni LG, Zanette G, Fiaschi A. Early and late intracortical inhibition in juvenile myoclonic epilepsy. Epilepsia. 2000;41:1129-1138.
25. Di Lazzaro V, Oliviero A, Mazzone P, et al. Direct demonstration of long latency cortico-cortical inhibition in normal subjects and in a patient with vascular parkinsonism. Clin Neurophysiol. 2002;113:1673-1679.
26. van der Kamp W, VanDenBrink A, Ferrari MD, can Dijk JG. Interictal cortical hyperexcitability in migraine patients demonstrated with transcranial magnetic stimulation. J Neurol Sci. 1996;139:106-110.
27. Ozturk V, Cakmur R, Donmez B, Yener GG, Kursad F, Idiman F. Comparison of cortical excitability in chronic migraine (transformed migraine) and migraine without aura. A transcranial magnetic stimulation study. J Neurol. 2002;249:1268-1271.
28. Gunaydin S, Soysal A, Atay T, Arpaci B. Motor and occipital cortex excitability in migraine patients. Can J Neurol Sci. 2006;33:63-67.
29. Aurora SK, Ahmad BK, Welch KM, Bhardhwaj P, Ramadan NM. Transcranial magnetic stimulation confirms hyperexcitability of occipital cortex in migraine. Neurology. 1998;50:1111-1114.
30. Gerwig M, Kastrup O, Meyer BU, Niehaus L. Evaluation of cortical excitability by motor and phosphene thresholds in transcranial magnetic stimulation. J Neurol Sci. 2003;215:75-78.
31. Di Lazzaro V, Oliviero A, Pilato F, et al. The physiological basis of transcranial motor cortex stimulation in conscious humans. Clin Neurophysiol. 2004;115:255-266.
32. Goadsby PJ, Classey JD. Glutamatergic transmission in the trigeminal nucleus assessed with local blood flow. Brain Res. 2000;875:119-124.
33. Gorji A. Spreading depression: A review of the clinical relevance. Brain Res Brain Res Rev. 2001;38:33-60.
34. Bereiter DA, Benetti AP. Excitatory amino acid release within spinal trigeminal nucleus after mustard oil injection into the temporomandibular joint region of the rat. Pain. 1996;67:451-459.
35. Johnson KW, Dieckman DK, Phebius LA. IGluR5 antagonists as novel migraine therapies. Cephalalgia. 2001;21:268.
36. Ferrari MD, Odink J, Bos KD, Malessy MJ, Bruyn GW. Neuroexcitatory plasma amino acids are elevated in migraine. Neurology. 1990;40:1582-1586.
37. Martinez F, Castillo J, Rodriguez JR, Leira R, Noya M. Neuroexcitatory amino acid levels in plasma and cerebrospinal fluid during migraine attacks. Cephalalgia. 1995;13:89-93.
38. Kaube H, Herzog J, Kaufer T, Dichgans M, Diener HC. Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine. Neurology. 2000;55:139-141.
39. Mathew NT. Antiepileptic drugs in migraine prevention. Headache. 2001;41(suppl 1):S18-S24.
40. Kirschner J, Moll GH, Fietzek UM, et al. Methylphenidate enhances both intracortical inhibition and facilitation in healthy adults. Pharmacopsychiatry. 2003;36:79-82.
41. Bares M, Kanovsky P, Klajblova H, Rektor I. Intracortical inhibition and facilitation are impared in patients with early Parkinson's disease: A paired TMS study. Eur J Neurol. 2003;10:385-389.
42. Del Zompo M, Cherchi A, Palmas MA, et al. Association between dopamine receptor genes and migraine without aura in a Sardinian sample. Neurology. 1998;51:781-786.
43. Mochi M, Cevoli S, Cortelli P, et al. A genetic association study of migraine with dopamine receptor 4, dopamine transporter and dopamine- betahydroxylase genes. Neurol Sci. 2003;23:301-305.
44. Del Zompo M. Dopaminergic hypersensitivity in migraine: Clinical and genetic evidence. Funct Neurol. 2000;15(suppl 3):163-170.
45. Sesack SR, Carr DB, Omelchenko N, Pinto A. Anatomical substrates for glutamate-dopamine interactions: Evidence for specificity of connections and extrasynaptic action. Ann NY Acad Sci. 2003;1003:36-52.